tiprankstipranks
Prothena (PRTA)
NASDAQ:PRTA
US Market

Prothena (PRTA) Technical Analysis

Compare
607 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Prothena’s (PRTA) Moving Averages Convergence Divergence (MACD) indicator is -0.12, suggesting Prothena is a Buy.
Prothena’s (PRTA) 20-Day exponential moving average is 14.27, while Prothena’s (PRTA) share price is $14.17, making it a Sell.
Prothena’s (PRTA) 50-Day exponential moving average is 14.64, while Prothena’s (PRTA) share price is $14.17, making it a Sell.

Prothena (PRTA) Pivot Points

Feb 16, 2025, 09:41 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.62
12.88
13.39
13.65
14.16
14.42
14.93
Fibonacci
12.88
13.18
13.36
13.65
13.95
14.13
14.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Prothena (PRTA) Moving Averages

Feb 16, 2025, 09:41 PM
Period
Simple
Exponential
MA5
13.95Buy
14.04Buy
MA10
14.09Buy
14.16Buy
MA20
14.55Sell
14.27Sell
MA50
14.23Sell
14.64Sell
MA100
15.56Sell
15.87Sell
MA200
18.53Sell
18.50Sell
Prothena’s (PRTA) 10-Day exponential moving average is 14.16, while Prothena’s (PRTA) share price is $14.17, making it a Buy.
Prothena’s (PRTA) 100-Day exponential moving average is 15.87, while Prothena’s (PRTA) share price is $14.17, making it a Sell.
Prothena’s (PRTA) stock price is $14.17 and Prothena’s (PRTA) 50-day simple moving average is 14.23, creating a Sell signal.
Prothena’s (PRTA) stock price is $14.17 and Prothena’s (PRTA) 100-day simple moving average is 15.56, creating a Sell signal.
Prothena’s (PRTA) stock price is $14.17 and Prothena’s (PRTA) 200-day simple moving average is 18.53, creating a Sell signal.

Prothena (PRTA) Technical Indicators

Feb 16, 2025, 09:41 PM
Name
Value
Implied Action
RSI (14)
48.60
Neutral
STOCH (9,6)
40.66
Neutral
STOCHRSI (14)
23.46
Neutral
MACD (12,26)
-0.12
Buy
ADX (14)
13.63
Buy
Williams %R
-69.55
Buy
CCI (14)
-43.08
Neutral
ATR (14)
0.94
-
Ultimate Oscillator
51.46
Neutral
ROC
-11.66
Sell
Prothena’s (PRTA) Relative Strength Index (RSI) is 48.60, creating a Neutral signal.
Prothena’s (PRTA) Trend Strength Indicator (ADX) is 13.63, creating a Buy signal.
Prothena’s (PRTA) Commodity Channel Index (CCI) is -43.08, creating a Neutral signal.
Prothena’s (PRTA) Price Rate of Change (ROC) is -11.66, creating a Sell signal.

FAQ

Is PRTA a Buy, Hold, or Sell?
Based on PRTA’s technical indicators, PRTA is a Sell.
    What is PRTA’s RSI (14)?
    PRTA’s RSI (14) is 48.60, which suggests PRTA is a Neutral.
      What is PRTA’s MACD?
      PRTA’s MACD is -0.12, which suggests PRTA is a Buy.
        What is PRTA’s 5-day moving average?
        PRTA’s 5-day moving average is 13.95, which suggests PRTA is a Buy.
          What is PRTA’s 20-day moving average?
          PRTA 20-day moving average is 14.55, which suggests PRTA is a Sell.
            What is PRTA’s 50-day moving average?
            PRTA’s 50-day moving average is 14.23, which suggests PRTA is a Sell.
              What is PRTA’s 200-day moving average?
              PRTA’s 200-day moving average is 18.53, which suggests PRTA is a Sell.
                What is PRTA’s Williams % R (14)?
                PRTA’s Williams % R (14) is -69.55, which suggests PRTA is a Buy.
                  What is PRTA’s CCI (14)?
                  PRTA’s CCI (14) is -43.08, which suggests PRTA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis